Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Example: Skip breakfast after dinner at 8 PM, and by noon, your liver has shifted gears
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors not yet approved by the MHRA or EMA for clinical use in the UK
As research progresses, Retatrutide is increasingly referenced as one of the more advanced incretin-based compounds currently under investigation
NAION is a severe eye complication that can lead to permanent vision loss
As of early 2024, the average out-of-pocket price in the United States ranges from $1,000 to $1,200 per month for standard doses, before insurance or discounts are applied
US$ 27.91
US$ 27.84
US$ 24.25
US$ 22.93
US$ 26.99
US$ 28.95
US$ 27.81
US$ 21.90
US$ 21.39
